Dyadic International Inc.

DYAI

Healthcare Biotechnology

Dyadic International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 million, down 11.6% from fiscal 2024.

Revenue
−61.4%
EPS
n/m
Free cash flow
n/m
Total debt
+0.80%

Quarter to September 2026, against a year earlier

0.33 0.02 −5.71%
Market cap
$14.0M
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
2/9
ROIC
0.00%
Net debt / EBITDA
0.5×
Payout ratio
—

Revenue to profit Fiscal 2025, year to 31 December 2025

It lost $7.4M on $3.1M of revenue: $238.31 for every $100. What is an income statement?

Revenue to profit, in billions of dollars and as a share of revenue
Revenue0.0100.0%
Cost of revenue0.0−75.1%
Gross profit0.024.9%
Research & development0.0−69.7%
Selling, general & admin0.0−186.4%
Other operating costs0.0−1.5%
Operating income0.0−232.8%
Other income, net0.0−5.6%
Net income0.0−238.3%
Revenue, operating income and net income, ten yearsRevenueOperating incomeNet incomeNet margin (right axis)
Revenue, operating income and net income, ten years
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Operating income$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Net income$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Net margin (right axis)0.0%−281.6%−439.4%−494.2%−582.1%−543.7%−332.2%−234.4%−166.2%−238.3%
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue
0.59 0.76 1.30 1.68 1.60 2.40 2.93 2.90 3.50 3.09
Revenue Growth
87.66% 27.89% 70.82% 29.76% (4.71%) 50.06% 21.90% (1.07%) 20.58% (11.59%)
Gross Profit
0.59 0.08 0.27 0.22 0.18 0.46 0.81 0.92 2.30 0.77
Operating Income
0.59 0.76 (7.59) (9.28) (10.03) (14.73) (10.17) (8.23) (5.90) (7.19)
EBT
0.59 (2.20) (6.70) (8.30) (9.29) (13.07) (9.74) (6.80) (5.81) (7.36)
Income after Tax
0.59 (2.27) (5.69) (8.31) (9.33) (13.07) (9.74) (6.80) (5.81) (7.36)
Net Income Common
(3.61) (2.14) (5.69) (8.31) (9.33) (13.07) (9.74) (6.80) (5.81) (7.36)
EPS (Diluted)
(0.10) (0.07) (0.21) (0.31) (0.34) (0.47) (0.34) (0.24) (0.20) (0.23)
Shares (Diluted, Weighted)
36.54 28.92 27.67 27.00 27.47 27.84 28.36 28.80 29.32 32.62
Gross Margin
100.00% 10.31% 20.70% 13.17% 11.05% 19.11% 27.54% 31.84% 65.82% 24.93%
EBIT Margin
100.00% (976.31%) (586.06%) (552.17%) (625.86%) (612.68%) (346.92%) (283.90%) (168.82%) (232.75%)
Net Profit Margin
(608.60%) (281.62%) (439.35%) (494.20%) (582.14%) (543.73%) (332.23%) (234.42%) (166.20%) (238.31%)
Free Cash Flow Margin
(1,017.77%) (223.00%) (340.19%) (344.00%) (410.41%) (469.13%) (275.87%) (232.05%) (113.72%) (184.52%)
EBITDA
0.59 (6.30) (6.92) (9.08) (9.69) (14.40) (10.13) (8.28) (5.91) (7.17)
EBIT
0.59 (7.40) (7.59) (9.28) (10.03) (14.73) (10.17) (8.23) (5.90) (7.19)

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 13 Nov 2026